We're excited to share that @MedStarHealth was the first research center in the U.S. to enroll a patient in a single-arm, multicenter prospective study to evaluate the safety and effectiveness of The RevCore™ Thrombectomy Catheter, a device designed to meet this unmet need for patients with venous thrombosis.
Read more about how RevCore is making an impact on patients: https://t.co/oOt9eP3lZd
More on #RevCore: https://t.co/IxV6qaur7b
2:00:35 NEW WR 🤯🤯
Are. You. Kidding. Me?! No longer IF but WHEN now before we see a sub-2 marathon. It’s a whole new world kids…
Kelvin Kiptum - we are not worthy. Bravo sir. #ChicagoMarathon
Dr. Edvard Skripochnik presented a case that supported stent shape doesn’t matter. Popliteal vein access, 100% IVUS, 100% post-dilation. "Don't be afraid of the Oval." @TheVEINSatVIVA#VIVA22
Don't forget! Join us @TheVEINSatVIVA for a lunch symposium on venous stenting from 12:15–1:15 pm TODAY in Petrus 1 at The Wynn Las Vegas. Presenters are Dr. Bobby Mendes & @GSalazar_MD w/case presentation by Dr. Edvard Skripochnik. Learn more ➡️ https://t.co/E1E9wB7KbG #VIVA22
Join us @TheVEINSatVIVA for a lunch symposium on venous stenting from 12:15–1:15 pm, Oct. 30, in Petrus 1 at The Wynn Las Vegas. Presenters are Dr. Bobby Mendes & @GSalazar_MD w/case presentation by Dr. Edvard Skripochnik. Learn more ➡️ https://t.co/E1E9wB7KbG #VIVA22
Join us @TheVEINSatVIVA for a lunch symposium on venous stenting from 12:15–1:15 pm, Oct. 30, in Petrus 1 at The Wynn Las Vegas. Presenters are Dr. Bobby Mendes & @GSalazar_MD w/case presentation by Dr. Edvard Skripochnik. Learn more ➡️ https://t.co/E1E9wB8i1e #VIVA22
Join us @TheVEINSatVIVA for a lunch symposium on venous stenting from 12:15–1:15 pm, Oct. 30, in Petrus 1 at The Wynn Las Vegas. Presenters are Dr. Bobby Mendes & @GSalazar_MD w/case presentation by Dr. Edvard Skripochnik. Learn more ➡️ https://t.co/E1E9wAQ8N6 #VIVA22
Drs. Kathleen Gibson (@KathleenGibson6), Gerard O’Sullivan, Suresh Vedantham, & Rick de Graaf share their views on the situations in which they will never stent, including specific anatomic concerns, patient characteristics, and procedural factors. https://t.co/WyzOFhbKUu
Join Drs. John Phillips and Sheila Blumberg for a hands-on perfused cadaveric workshop on "Complex Retrograde Tibiopedal Access and Managing Iliofemoral Venous Obstruction Course" Aug 19-20 in NY. Register ➡️ https://t.co/ER7ghGGEjm @MidOhioVascular#CookVista#MedEd
Join us for a virtual webinar tomorrow at 7:30 pm ET, "Your Second Tool: Using Data to Drive Decision Making." Moderator @DrSteveElias joins faculty Dr. Anthony Comerota & @kush_r_desai to discuss using data in decision making. Register ➡️ https://t.co/qUwLLd02uU @VenousSymposium
Join us for virtual webinar "Your Second Tool: Using Data to Drive Decision Making" on July 12 at 7:30 pm ET. Moderator @DrSteveElias joins faculty Dr. Anthony Comerota & @kush_r_desai to discuss using data in decision making. Register ➡️ https://t.co/qUwLLd02uU @VenousSymposium
As the venous stent market expands, it’s a good reminder to look at the data available.
“Zilver Vena is associated with a high rate of patency by ultrasound (90.3% ± 2.2%) three years after the initial procedure.”
Also at 3 YEARS, ZERO stent fractures. https://t.co/yUSM1EobZf
Meet the Experts: Join Drs. Paul Gagne and Kush Desai virtually for "A discussion around the VIVO 3-year subset results" on Saturday, April 23, at 1:04 pm (EDT). Register ➡️ https://t.co/6J1jV0CDcR #veins#venous@kush_r_desai@VenousSymposium